Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BCA356
i
Other names:
BCA356
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Biocon
Drug class:
Carbonic anhydrase IX inhibitor, IL-12 modulator
Related drugs:
‹
TLX250 (0)
CA9hu-1 (0)
ITM-91 (0)
girentuximab (0)
SLC-0111 (0)
SLC-149 (0)
ABO2011 (0)
RPTR-168 (0)
TLX250 (0)
CA9hu-1 (0)
ITM-91 (0)
girentuximab (0)
SLC-0111 (0)
SLC-149 (0)
ABO2011 (0)
RPTR-168 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
CA9 overexpression
Solid Tumor
CA9 overexpression
Solid Tumor
BCA356
Sensitive: D – Preclinical
BCA356
Sensitive
:
D
BCA356
Sensitive: D – Preclinical
BCA356
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login